Jon E. Angell

Array ( [id] => 5446965 [patent_doc_number] => 20090048191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Therapeutic molecules for modulating stability of vegf' [patent_app_type] => utility [patent_app_number] => 11/547339 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18059 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048191.pdf [firstpage_image] =>[orig_patent_app_number] => 11547339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648628 [patent_doc_number] => 08802639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'RNA interference modulators of hedgehog signaling and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/088691 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 47880 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11088691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4719303 [patent_doc_number] => 20080241825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Materials and Methods for Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 10/593597 [patent_app_country] => US [patent_app_date] => 2005-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16272 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241825.pdf [firstpage_image] =>[orig_patent_app_number] => 10593597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821025 [patent_doc_number] => 20060025338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Compositions and methods for treatment of lymphatic and venous vessel arterialization' [patent_app_type] => utility [patent_app_number] => 11/076427 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 37955 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025338.pdf [firstpage_image] =>[orig_patent_app_number] => 11076427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220378 [patent_doc_number] => 20050260709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Lipin1 function' [patent_app_type] => utility [patent_app_number] => 11/071581 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14797 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260709.pdf [firstpage_image] =>[orig_patent_app_number] => 11071581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945264 [patent_doc_number] => 20050197313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Multiple promoter expression cassettes for simultaneous delivery of RNAi agents' [patent_app_type] => utility [patent_app_number] => 11/072592 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 19549 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197313.pdf [firstpage_image] =>[orig_patent_app_number] => 11072592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924047 [patent_doc_number] => 20060241069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Treatment of hyperproliferative disease' [patent_app_type] => utility [patent_app_number] => 10/529650 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6203 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241069.pdf [firstpage_image] =>[orig_patent_app_number] => 10529650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6932979 [patent_doc_number] => 20050283847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Inhibition of gene expression using polynucleotide analogues' [patent_app_type] => utility [patent_app_number] => 11/057276 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19379 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0283/20050283847.pdf [firstpage_image] =>[orig_patent_app_number] => 11057276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682813 [patent_doc_number] => 20080249039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Modified Short Interfering Rna (Modified Sirna)' [patent_app_type] => utility [patent_app_number] => 10/587775 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14725 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249039.pdf [firstpage_image] =>[orig_patent_app_number] => 10587775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7196854 [patent_doc_number] => 20050164394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Methods and means for producing efficient silencing construct using recombinational cloning' [patent_app_type] => utility [patent_app_number] => 11/034069 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13158 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164394.pdf [firstpage_image] =>[orig_patent_app_number] => 11034069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600402 [patent_doc_number] => 20100098663 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2010-04-22 [patent_title] => 'Methods of Inhibiting Tumor Cell Proliferation with FoxM1 siRNA' [patent_app_type] => utility [patent_app_number] => 11/571030 [patent_app_country] => US [patent_app_date] => 2005-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11782 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0098/20100098663.pdf [firstpage_image] =>[orig_patent_app_number] => 11571030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600402 [patent_doc_number] => 20100098663 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2010-04-22 [patent_title] => 'Methods of Inhibiting Tumor Cell Proliferation with FoxM1 siRNA' [patent_app_type] => utility [patent_app_number] => 11/571030 [patent_app_country] => US [patent_app_date] => 2005-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11782 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0098/20100098663.pdf [firstpage_image] =>[orig_patent_app_number] => 11571030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983854 [patent_doc_number] => 20050153924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Antisense modulation of interferon gamma receptor 2' [patent_app_type] => utility [patent_app_number] => 11/013543 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26056 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153924.pdf [firstpage_image] =>[orig_patent_app_number] => 11013543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977403 [patent_doc_number] => 20050287119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Methods and compositions for treatment of interferon-resistant tumors' [patent_app_type] => utility [patent_app_number] => 11/009689 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11597 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287119.pdf [firstpage_image] =>[orig_patent_app_number] => 11009689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967103 [patent_doc_number] => 20050234000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'SiRNA delivery into mammalian nerve cells' [patent_app_type] => utility [patent_app_number] => 11/009797 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16502 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234000.pdf [firstpage_image] =>[orig_patent_app_number] => 11009797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7039410 [patent_doc_number] => 20050158844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods for eliminating or reducing the expression of a genes in a filamentous fungal strains' [patent_app_type] => utility [patent_app_number] => 11/009890 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23838 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158844.pdf [firstpage_image] =>[orig_patent_app_number] => 11009890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983850 [patent_doc_number] => 20050153920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Ribozymes used as prodrugs' [patent_app_type] => utility [patent_app_number] => 11/000191 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4122 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153920.pdf [firstpage_image] =>[orig_patent_app_number] => 11000191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766721 [patent_doc_number] => 20060018884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent' [patent_app_type] => utility [patent_app_number] => 10/995614 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3451 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018884.pdf [firstpage_image] =>[orig_patent_app_number] => 10995614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770870 [patent_doc_number] => 20050266561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Use of interfering RNA in the production of transgenic animals' [patent_app_type] => utility [patent_app_number] => 10/996217 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 48817 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266561.pdf [firstpage_image] =>[orig_patent_app_number] => 10996217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8352054 [patent_doc_number] => 08247383 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Drug-carrier complexes and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/994213 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 14623 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10994213 [rel_patent_id] =>[rel_patent_doc_number] =>)